vimarsana.com
Home
Live Updates
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan : vimarsana.com
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the first patient has been enrolled...
Related Keywords
Japan ,
Tokyo ,
London ,
City Of ,
United Kingdom ,
Amsterdam ,
Noord Holland ,
Netherlands ,
United States ,
Canada ,
Australia ,
America ,
Hirokazu Kanegane ,
Claire Dobbs ,
Ethan Metelenis ,
Heather Robertson ,
Anurag Relan ,
Michael Levitan ,
Devices Agency ,
Ministry Of Health ,
Prnewswire Pharming Groupnv ,
European Medicines Agency ,
Vp Investor Relations Corporate Communications ,
Investor Relations Corporate Communications ,
Japan Pharmaceuticals ,
Professor Of The Department Child Health ,
Drug Administration ,
Pharming Group ,
Nasdaq ,
Lifespring Life Sciences Communication ,
Exchange Commission ,
Single Arm Phase ,
Medical Devices Agency ,
Child Health ,
Tokyo Medical ,
Dental University ,
Chief Medical Officer ,
United States Food ,
Activated Phosphoinositide ,
North America ,
Middle East ,
Looking Statements ,
Annual Report ,
Allergy Clin ,
Rev Allergy ,
Corporate Communications ,
Investor Relations ,
Corporate Communications Manager ,
Amy Byrne ,
Spring Life Sciences Communication ,
Pharming Groupnv ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Biotechnology ,
Pharmaceuticals ,
Banking Amp Financial Services ,
Clinical Trials Amp Medical Discoveries ,
vimarsana.com © 2020. All Rights Reserved.